# Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.

> **NCT07491042** · NA · RECRUITING · sponsor: **Oman Ministry of Health** · enrollment: 38 (estimated)

## Conditions studied

- End Stage Chronic Renal Failure

## Interventions

- **DRUG:** Dapagliflozin

## Key facts

- **NCT ID:** NCT07491042
- **Lead sponsor:** Oman Ministry of Health
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-01-31
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07491042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07491042, "Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT07491042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*